A separate product, semaglutide subcutaneous injection (Wegovy), is indicated as an adjunct to lifestyle modifications for weight loss and chronic weight management in obese (BMI 30 kg/m2 or greater) or overweight adults (BMI 27 kg/m2 or greater) with at least 1 weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)
Expert-Guided, Sustainable Weight Loss Discover how proven medications such as semaglutide or tirzepatide, combined with expert support, can help you reach lasting weight loss results
The markings on the syringe directly corresponded to the dose
Many people, particularly during sleep, breathe through their mouths without awareness
In some cases, rapid weight gain occurred after discontinuation an indication that long-term success depends heavily on lifestyle